World · India Bureau
Dr Lal PathLabs declares Rs 5 dividend as Q2 profit surges 28%
The diagnostic services company reported consolidated net profit of Rs 192.2 crore for the September quarter, marking strong year-on-year growth. The board has approved a dividend payout to shareholders.
LSN India ·
Dr Lal PathLabs has announced a dividend of Rs 5 per share, rewarding investors as the healthcare diagnostics provider delivered robust financial performance in the second quarter ended September 2026.
The company posted consolidated net profit of Rs 192.2 crore during the quarter, representing growth of 27.6% compared with Rs 150.6 crore in the corresponding period of the previous financial year. The strong profit expansion underscores improving operational efficiency and growing demand for diagnostic services across the company's service centres.
The dividend declaration reflects the company's confidence in sustained earnings growth and its commitment to returning value to shareholders. The payout comes as diagnostic service providers continue to benefit from rising health awareness and increased adoption of preventive healthcare across India.
Dr Lal PathLabs operates one of the country's largest networks of diagnostic centres and has established itself as a key player in the organised diagnostics segment. The quarter's results demonstrate the resilience of the healthcare services sector and the company's ability to maintain profitability amid operational challenges.